---
title: "IRADIMED CORPORATION (IRMD.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/IRMD.US.md"
symbol: "IRMD.US"
name: "IRADIMED CORPORATION"
industry: "醫療器械"
---

# IRADIMED CORPORATION (IRMD.US)

| Item | Detail |
|------|--------|
| Industry | 醫療器械 |
| Location | 美股市場 |
| Website | [www.iradimed.com](https://www.iradimed.com) |

## Company Profile

IRADIMED CORPORATION 開發、制造、營銷和分銷與磁共振成像（MRI）兼容的醫療設備及相關配件、一次性用品和服務，業務遍及美國及國際市場。該公司提供與 MRI 兼容的 MRidium 靜脈輸液泵系統及相關的一次性靜脈輸液管套件；MRI 兼容的患者生命體徵監測系統；以及帶有遠程報警記錄單元的 3600 FMD1 磁性檢測設備。它還提供非磁性靜脈輸液桿、無線遠程顯示/控制、側車泵模塊、劑量錯誤減少系統，以及帶傳感器和配件的 SpO2 監測。該公司服務于醫院、急救設施和門診影像中心

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:13.000Z

**Overall: B (0.23)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 25 / 185 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 14.43% |  |
| Net Profit YoY | 16.88% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 13.56 |  |
| Dividend Ratio | 1.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.28B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 83.81M |  |


**Multi Score**: B

#### Profit Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 24.78% | A |
| Profit Margin | 26.82% | A |
| Gross Margin | 76.75% | A |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 14.43% | B |
| Net Profit YoY | 16.88% | B |
| Total Assets YoY | 10.63% | B |
| Net Assets YoY | 8.98% | B |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 372.84% | C |
| OCF YoY | 14.43% | B |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.81 | B |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 13.02% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - IRADIMED CORPORATION",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "A",
      "indicators": [
        {
          "name": "ROE",
          "value": "24.78%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "26.82%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "76.75%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "14.43%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "16.88%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "10.63%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "8.98%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "372.84%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "14.43%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.81",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "13.02%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 啟迪醫療 (US.INSP) | A | B | A | A | B | A |
| 02 | Delcath (US.DCTH) | C | A | A | A | A | A |
| 03 | 直覺外科 (US.ISRG) | A | B | C | A | B | B |
| 04 | 史賽克 (US.SYK) | A | B | C | C | B | B |
| 05 | 波士頓科學 (US.BSX) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 57.08 | 33/181 | 56.48 | 43.34 | 35.05 |
| PB | 13.56 | 125/181 | 12.23 | 9.49 | 7.77 |
| PS (TTM) | 15.31 | 121/181 | 14.94 | 11.53 | 9.20 |
| Dividend Yield | 1.00% | 13/181 | 1.17% | 1.03% | 0.90% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-10T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 103.89 |
| Highest Target | 100.00 |
| Lowest Target | 98.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/IRMD.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/IRMD.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/IRMD.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.